Skip to main content
OpenTrials
Completed

NCT Number: NCT04984694

Computerized Virtual Reality in Elderly

The number of dementia patients increased with aging population. People with subjective memory complaints or mild cognitive impairment (MCI) may have a high risk of developing dementia. Cognitive /memory training programs have shown the potential positive effects for improving or maintaining the cognitive progression. However, the impact of those cognitive progressions on functional ability and quality of life is not well understood. In addition, it appears to have large variability responsiveness among trained subjects. Most studies did not examine the individual difference associated with training. The major aim will evaluate the cognitive training programs on functional ability and quality of life in older adults. The results will be expected to understand the effectiveness of the computerized virtual reality training, improving or maintaining cognition, physical and psychosocial function, enhancing quality of life, and reducing the risk of developing disability even conversion into dementia in later life.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

TMU-Shuang-Ho Hospital, Taipei Medical University

New Taipei City, 23561, Taiwan

About this study

Prevention strategies for dementia are needed because of the increasing prevalence of dementia. People with mild cognitive impairment are at high risk of developing a disability, even conversion into dementia in later life. Cognitive /memory training programs have shown the potential positive effects for improving or maintaining the cognitive progression. However, the impact of those cognitive progressions on functional ability and quality of life is not well understood. The major aim of this total project is to evaluate the short and long-term effects of computerized virtual reality training programs (Xavix Hot-Plus) on functional ability (cognition, physical and psychosocial function) and quality of life in older adults with mild cognitive impairment.

The experimental research design with three groups, one pretest and four posttests will be conducted to examine the short-term and long-term effects on cognition (primary outcome), physical (secondary outcome), psychosocial function (secondary outcome), and quality of life (secondary outcome). Independent adults will be recruited from the community base on sample criteria. The total subjects will be 160 to 190 older adults and the community care centers include all eligible participants will be randomly assigned into computerized virtual reality training programs group (Hot-Plus group) or social interaction group. The subjects for the control group will be recruited in the community and be referred by neurological, psychiatric, or gerontological physicians.

Participants who are in the Hot-Plus group will divide several small groups which will be 4 persons with mild cognitive impairment. Participants will receive a computerized virtual reality training program by Hot-Plus as a group activity one hour, once a week for 12 weeks. The participants in the social interaction group will come as a group for social interaction one hour weekly for 12 weeks. The control group will maintain their regular activities.

Data will be analysed by using SPSS version 18.0 (SPSS, Chicago, IL), with the significance level is set at p< .05. The normal distribution of the data will be evaluated using the Kolmogorov-Smirnov test. Mean, Standard deviation, frequency, and percentage will be performed to describe all variables. One-way analysis of variance (ANOVA) will be used to evaluate differences between groups according to the continuous variables, non-normal distribution of data will be calculated by Kruskasl-Wallis test. The chi-square test will be used for the comparison of categorical variables, and Fisher's exact test will be used due to the expected value less than four. Generalised Estimating Equation (GEE) will be used to examine the main effects, time effects, and interactions in outcomes over time.

The results will be expected to understand the effectiveness of the computerized virtual reality training, improving or maintaining cognition, physical, psychosocial function, enhancing quality of life, and reducing the risk of developing disability even conversion into dementia in later life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Equal to or older than 60 years old
  • The SPMSQ scores range from 4-7 ( illiterate: 4-5, elementary: 5-6, junior high school: 6-7) or Clinical Dementia Rating Scale (CDR): 0.5
  • Be able to communicate in Mandarin or Taiwanese
  • Has the ability to see and hear well enough to follow the instructions
  • Agree to participate in this study.

Exclusion criteria

  • Activity restrictions from physician recommendation
  • Unstable disease progress could affect their participation
  • Surgery for joints or spinal cord within 6 months
  • Unable to walk 50 meters with the assistant device
  • Learning disability

Treatment and study plan

Computerized virtual reality training programs group (Hot-Plus group)

Behavioral

In this study, the investigators utilised interactive-video games called "Xavix Hot Plus"(Hot-plus, Shinsedai[SSD] Co. Ltd, Shiga Japan), which was designed specifically for rehabilitation and reported high participant motivation and enjoyment while playing.

Social interaction group

Behavioral

The social interaction group will get together as a group for social interaction one hour weekly for 12 weeks.

Primary outcomes

  1. Cognition-Global cognition

    Time frame: At baseline.

    Global cognition was measured by the Mini-Mental State Examination (MMSE), a modified version of a neuropsychological battery in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), which maximum score was 30 including orientation, memory, concentration, language, and praxis (Folstein, Folstein, & McHugh, 1975; Morris et al., 1989).

  2. Cognition-Global cognition

    Time frame: Immediately after intervention.

    Global cognition was measured by the Mini-Mental State Examination (MMSE), a modified version of a neuropsychological battery in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), which maximum score was 30 including orientation, memory, concentration, language, and praxis (Folstein, Folstein, & McHugh, 1975; Morris et al., 1989).

  3. Cognition-Global cognition

    Time frame: At 4 weeks after intervention.

    Global cognition was measured by the Mini-Mental State Examination (MMSE), a modified version of a neuropsychological battery in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), which maximum score was 30 including orientation, memory, concentration, language, and praxis (Folstein, Folstein, & McHugh, 1975; Morris et al., 1989).

  4. Cognition-Global cognition

    Time frame: At 12 weeks after intervention.

    Global cognition was measured by the Mini-Mental State Examination (MMSE), a modified version of a neuropsychological battery in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), which maximum score was 30 including orientation, memory, concentration, language, and praxis (Folstein, Folstein, & McHugh, 1975; Morris et al., 1989).

  5. Cognition-Global cognition

    Time frame: At 24 weeks after intervention.

    Global cognition was measured by the Mini-Mental State Examination (MMSE), a modified version of a neuropsychological battery in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), which maximum score was 30 including orientation, memory, concentration, language, and praxis (Folstein, Folstein, & McHugh, 1975; Morris et al., 1989).

  6. Cognition-memory

    Time frame: At baseline.

    Memory was measured by the Word List test, contained three types as following (Morris et al., 1989; Welsh et al., 1994): 1) Immediately recall; 2) Delayed recall; 3) Recognition.

  7. Cognition-memory

    Time frame: Immediately after intervention.

    Memory was measured by the Word List test, contained three types as following (Morris et al., 1989; Welsh et al., 1994): 1) Immediately recall; 2) Delayed recall; 3) Recognition.

  8. Cognition-memory

    Time frame: At 4 weeks after intervention.

    Memory was measured by the Word List test, contained three types as following (Morris et al., 1989; Welsh et al., 1994): 1) Immediately recall; 2) Delayed recall; 3) Recognition.

  9. Cognition-memory

    Time frame: At 12 weeks after intervention.

    Memory was measured by the Word List test, contained three types as following (Morris et al., 1989; Welsh et al., 1994): 1) Immediately recall; 2) Delayed recall; 3) Recognition.

  10. Cognition-memory

    Time frame: At 24 weeks after intervention.

    Memory was measured by the Word List test, contained three types as following (Morris et al., 1989; Welsh et al., 1994): 1) Immediately recall; 2) Delayed recall; 3) Recognition.

  11. Cognition-attention

    Time frame: At baseline.

    Attention was measured by the Digit Span (DS) subtest from the Taiwan version of the Wechsler Adult Intelligence Scale-Ⅲ (WAIS-IV; Wechsler, 2002), which contained two components: DS forward and DS backward.

  12. Cognition-attention

    Time frame: Immediately after intervention.

    Attention was measured by the Digit Span (DS) subtest from the Taiwan version of the Wechsler Adult Intelligence Scale-Ⅲ (WAIS-IV; Wechsler, 2002), which contained two components: DS forward and DS backward.

  13. Cognition-attention

    Time frame: At 4 weeks after intervention.

    Attention was measured by the Digit Span (DS) subtest from the Taiwan version of the Wechsler Adult Intelligence Scale-Ⅲ (WAIS-IV; Wechsler, 2002), which contained two components: DS forward and DS backward.

  14. Cognition-attention

    Time frame: At 12 weeks after intervention.

    Attention was measured by the Digit Span (DS) subtest from the Taiwan version of the Wechsler Adult Intelligence Scale-Ⅲ (WAIS-IV; Wechsler, 2002), which contained two components: DS forward and DS backward.

  15. Cognition-attention

    Time frame: At 24 weeks after intervention.

    Attention was measured by the Digit Span (DS) subtest from the Taiwan version of the Wechsler Adult Intelligence Scale-Ⅲ (WAIS-IV; Wechsler, 2002), which contained two components: DS forward and DS backward.

  16. Cognition-visual/spatial function

    Time frame: At baseline.

    Visual/spatial function was measured by the Clock Drawing Test (CDT). Participants were asked to draw a clock face, place all the numbers on it, and set the time to 11 past 10 (Powlishta et al., 2002; Shulman, Shedletsky, & Silver, 1986).

  17. Cognition-visual/spatial function

    Time frame: Immediately after intervention.

    Visual/spatial function was measured by the Clock Drawing Test (CDT). Participants were asked to draw a clock face, place all the numbers on it, and set the time to 11 past 10 (Powlishta et al., 2002; Shulman, Shedletsky, & Silver, 1986).

  18. Cognition-visual/spatial function

    Time frame: At 4 weeks after intervention.

    Visual/spatial function was measured by the Clock Drawing Test (CDT). Participants were asked to draw a clock face, place all the numbers on it, and set the time to 11 past 10 (Powlishta et al., 2002; Shulman, Shedletsky, & Silver, 1986).

  19. Cognition-visual/spatial function

    Time frame: At 12 weeks after intervention.

    Visual/spatial function was measured by the Clock Drawing Test (CDT). Participants were asked to draw a clock face, place all the numbers on it, and set the time to 11 past 10 (Powlishta et al., 2002; Shulman, Shedletsky, & Silver, 1986).

  20. Cognition-visual/spatial function

    Time frame: At 24 weeks after intervention.

    Visual/spatial function was measured by the Clock Drawing Test (CDT). Participants were asked to draw a clock face, place all the numbers on it, and set the time to 11 past 10 (Powlishta et al., 2002; Shulman, Shedletsky, & Silver, 1986).

  21. Cognition-executive function

    Time frame: At baseline.

    Executive function was measured by the Stroop Color and Word Test (SCWT)(Golden et al., 2002). It consisted of three subtasks: word reading (RED, GREEN, and BLUE), color naming (XXXX's colored in red, green, or blue ink), and incongruent color-word naming (the words RED, GREEN, and BLUE printed in not matching red, green, or blue ink).

  22. Cognition-executive function

    Time frame: Immediately after intervention.

    Executive function was measured by the Stroop Color and Word Test (SCWT)(Golden et al., 2002). It consisted of three subtasks: word reading (RED, GREEN, and BLUE), color naming (XXXX's colored in red, green, or blue ink), and incongruent color-word naming (the words RED, GREEN, and BLUE printed in not matching red, green, or blue ink).

  23. Cognition-executive function

    Time frame: At 4 weeks after intervention.

    Executive function was measured by the Stroop Color and Word Test (SCWT)(Golden et al., 2002). It consisted of three subtasks: word reading (RED, GREEN, and BLUE), color naming (XXXX's colored in red, green, or blue ink), and incongruent color-word naming (the words RED, GREEN, and BLUE printed in not matching red, green, or blue ink).

  24. Cognition-executive function

    Time frame: At 12 weeks after intervention.

    Executive function was measured by the Stroop Color and Word Test (SCWT)(Golden et al., 2002). It consisted of three subtasks: word reading (RED, GREEN, and BLUE), color naming (XXXX's colored in red, green, or blue ink), and incongruent color-word naming (the words RED, GREEN, and BLUE printed in not matching red, green, or blue ink).

  25. Cognition-executive function

    Time frame: At 24 weeks after intervention.

    Executive function was measured by the Stroop Color and Word Test (SCWT)(Golden et al., 2002). It consisted of three subtasks: word reading (RED, GREEN, and BLUE), color naming (XXXX's colored in red, green, or blue ink), and incongruent color-word naming (the words RED, GREEN, and BLUE printed in not matching red, green, or blue ink).

Secondary outcomes

  1. Physical function-IADL

    Time frame: At baseline.

    Instrumental Activities of Daily Living (IADL) were evaluated with eight abilities, including shopping, transportation, meal preparation, ordinary housework, doing laundry, medications, phone use, and managing finances. Individual items are summed to produce a scale that ranges from 0 to 8 (Lawton, & Brody; 1969; Pashmdarfard & Azad, 2020).

  2. Physical function-IADL

    Time frame: Immediately after intervention.

    IADL was evaluated with eight abilities including shopping, transportation, meal preparation, ordinary housework, doing laundry, medications, phone use, and managing finances. Individual items are summed to produce a scale that ranges from 0 to 8 (Lawton, & Brody; 1969; Pashmdarfard & Azad, 2020).

  3. Physical function-IADL

    Time frame: At 4 weeks after intervention.

    IADL was evaluated with eight abilities including shopping, transportation, meal preparation, ordinary housework, doing laundry, medications, phone use, and managing finances. Individual items are summed to produce a scale that ranges from 0 to 8 (Lawton, & Brody; 1969; Pashmdarfard & Azad, 2020).

  4. Physical function-IADL

    Time frame: At 12 weeks after intervention.

    IADL was evaluated with eight abilities including shopping, transportation, meal preparation, ordinary housework, doing laundry, medications, phone use, and managing finances. Individual items are summed to produce a scale that ranges from 0 to 8 (Lawton, & Brody; 1969; Pashmdarfard & Azad, 2020).

  5. Physical function-IADL

    Time frame: At 24 weeks after intervention.

    IADL was evaluated with eight abilities including shopping, transportation, meal preparation, ordinary housework, doing laundry, medications, phone use, and managing finances. Individual items are summed to produce a scale that ranges from 0 to 8 (Lawton, & Brody; 1969; Pashmdarfard & Azad, 2020).

  6. Physical function-senior fitness test (SFT)

    Time frame: At baseline.

    A series of functional test include chair stand test, 8-ft up and go test, chair sit and reach test, 6-min walk test, and unipedal stance test was developed by Rikli & Jones.

    It has good reliability and validity and test-retest reliability is above 0.9 (Rikli & Jones, 2001).

  7. Physical function-senior fitness test (SFT)

    Time frame: Immediately after intervention.

    A series of functional test include chair stand test, 8-ft up and go test, chair sit and reach test, 6-min walk test, and unipedal stance test was developed by Rikli & Jones.

    It has good reliability and validity and test-retest reliability is above 0.9 (Rikli & Jones, 2001).

  8. Physical function-senior fitness test (SFT)

    Time frame: At 4 weeks after intervention.

    A series of functional test include chair stand test, 8-ft up and go test, chair sit and reach test, 6-min walk test, and unipedal stance test was developed by Rikli & Jones.

    It has good reliability and validity and test-retest reliability is above 0.9 (Rikli & Jones, 2001).

  9. Physical function-senior fitness test (SFT)

    Time frame: At 12 weeks after intervention.

    A series of functional test include chair stand test, 8-ft up and go test, chair sit and reach test, 6-min walk test, and unipedal stance test was developed by Rikli & Jones.

    It has good reliability and validity and test-retest reliability is above 0.9 (Rikli & Jones, 2001).

  10. Physical function-senior fitness test (SFT)

    Time frame: At 24 weeks after intervention.

    A series of functional test include chair stand test, 8-ft up and go test, chair sit and reach test, 6-min walk test, and unipedal stance test was developed by Rikli & Jones.

    It has good reliability and validity and test-retest reliability is above 0.9 (Rikli & Jones, 2001).

  11. Physical function-unipedal stance test (UST)

    Time frame: At baseline.

    Unipedal stance test was used to examine the static balance on the preferred leg. Participants performed three trials with the eyes open during the test (Goldberg, Casby, & Wasielewski, 2011) .

  12. Physical function-unipedal stance test (UST)

    Time frame: Immediately after intervention.

    Unipedal stance test was used to examine the static balance on the preferred leg. Participants performed three trials with the eyes open during the test (Goldberg, Casby, & Wasielewski, 2011) .

  13. Physical function-unipedal stance test (UST)

    Time frame: At 4 weeks after intervention.

    Unipedal stance test was used to examine the static balance on the preferred leg. Participants performed three trials with the eyes open during the test (Goldberg, Casby, & Wasielewski, 2011) .

  14. Physical function-unipedal stance test (UST)

    Time frame: At 12 weeks after intervention.

    Unipedal stance test was used to examine the static balance on the preferred leg. Participants performed three trials with the eyes open during the test (Goldberg, Casby, & Wasielewski, 2011) .

  15. Physical function-unipedal stance test (UST)

    Time frame: At 24 weeks after intervention.

    Unipedal stance test was used to examine the static balance on the preferred leg. Participants performed three trials with the eyes open during the test (Goldberg, Casby, & Wasielewski, 2011) .

  16. Psychosocial factors-Global Well-Being Scale (GWBS)

    Time frame: At baseline.

    Global Well-Being Scale (GWBS): It is a 10-centimeter visual analog scale to measures individuals' perception of well-being. The score of GWBS ranged from 0 to 10 (Hawk et al., 2010).

    Analog Scale (VAS) with a ten-centimeter horizontal line (Hawk et al., 2010).

  17. Psychosocial factors-Global Well-Being Scale (GWBS)

    Time frame: Immediately after intervention.

    Global Well-Being Scale (GWBS): It is a 10-centimeter visual analog scale to measures individuals' perception of well-being. The score of GWBS ranged from 0 to 10 (Hawk et al., 2010).

    Analog Scale (VAS) with a ten-centimeter horizontal line (Hawk et al., 2010).

  18. Psychosocial factors-Global Well-Being Scale (GWBS)

    Time frame: At 4 weeks after intervention.

    Global Well-Being Scale (GWBS): It is a 10-centimeter visual analog scale to measures individuals' perception of well-being. The score of GWBS ranged from 0 to 10 (Hawk et al., 2010).

    Analog Scale (VAS) with a ten-centimeter horizontal line (Hawk et al., 2010).

  19. Psychosocial factors-Global Well-Being Scale (GWBS)

    Time frame: At 12 weeks after intervention.

    Global Well-Being Scale (GWBS): It is a 10-centimeter visual analog scale to measures individuals' perception of well-being. The score of GWBS ranged from 0 to 10 (Hawk et al., 2010).

    Analog Scale (VAS) with a ten-centimeter horizontal line (Hawk et al., 2010).

  20. Psychosocial factors-Global Well-Being Scale (GWBS)

    Time frame: At 24 weeks after intervention.

    Global Well-Being Scale (GWBS): It is a 10-centimeter visual analog scale to measures individuals' perception of well-being. The score of GWBS ranged from 0 to 10 (Hawk et al., 2010).

    Analog Scale (VAS) with a ten-centimeter horizontal line (Hawk et al., 2010).

  21. Psychosocial factors-Interpersonal Relationship Scale (IRS)

    Time frame: At baseline.

    This scale was developed by Chang and Su (2011) in order to know the interpersonal relationship for middle-aged and older Adults.

    It's composed of 22 questions related to the interpersonal relationship: close interaction, approach to others, and friendship support (Chang & Su, 2011).

  22. Psychosocial factors-Interpersonal Relationship Scale (IRS)

    Time frame: Immediately after intervention.

    This scale was developed by Chang and Su (2011) in order to know the interpersonal relationship for middle-aged and older Adults.

    It's composed of 22 questions related to the interpersonal relationship: close interaction, approach to others, and friendship support (Chang & Su, 2011).

  23. Psychosocial factors-Interpersonal Relationship Scale (IRS)

    Time frame: At 4 weeks after intervention.

    This scale was developed by Chang and Su (2011) in order to know the interpersonal relationship for middle-aged and older Adults.

    It's composed of 22 questions related to the interpersonal relationship: close interaction, approach to others, and friendship support (Chang & Su, 2011).

  24. Psychosocial factors-Interpersonal Relationship Scale (IRS)

    Time frame: At 12 weeks after intervention.

    This scale was developed by Chang and Su (2011) in order to know the interpersonal relationship for middle-aged and older Adults.

    It's composed of 22 questions related to the interpersonal relationship: close interaction, approach to others, and friendship support (Chang & Su, 2011).

  25. Psychosocial factors-Interpersonal Relationship Scale (IRS)

    Time frame: At 24 weeks after intervention.

    This scale was developed by Chang and Su (2011) in order to know the interpersonal relationship for middle-aged and older Adults.

    It's composed of 22 questions related to the interpersonal relationship: close interaction, approach to others, and friendship support (Chang & Su, 2011).

  26. Psychosocial factors-Geriatric Depression Scale-Short Form (GDS-SF)

    Time frame: At baseline.

    Chinese version of the GDS-S consisted 15 items with yes/no questions and higher scores indicate a more severe level of depression (Lu, Liu, & Yu, 1998; Pfeiffer, 1975).

  27. Psychosocial factors-Geriatric Depression Scale-Short Form (GDS-SF)

    Time frame: Immediately after intervention.

    Chinese version of the GDS-S consisted 15 items with yes/no questions and higher scores indicate a more severe level of depression (Lu, Liu, & Yu, 1998; Pfeiffer, 1975).

  28. Psychosocial factors-Geriatric Depression Scale-Short Form (GDS-SF)

    Time frame: At 4 weeks after intervention.

    Chinese version of the GDS-S consisted 15 items with yes/no questions and higher scores indicate a more severe level of depression (Lu, Liu, & Yu, 1998; Pfeiffer, 1975).

  29. Psychosocial factors-Geriatric Depression Scale-Short Form (GDS-SF)

    Time frame: At 12 weeks after intervention.

    Chinese version of the GDS-S consisted 15 items with yes/no questions and higher scores indicate a more severe level of depression (Lu, Liu, & Yu, 1998; Pfeiffer, 1975).

  30. Psychosocial factors-Geriatric Depression Scale-Short Form (GDS-SF)

    Time frame: At 24 weeks after intervention.

    Chinese version of the GDS-S consisted 15 items with yes/no questions and higher scores indicate a more severe level of depression (Lu, Liu, & Yu, 1998; Pfeiffer, 1975).

  31. Quality of Life-EQ5D-Utility

    Time frame: At baseline.

    EQ-5D-3L Taiwanese version questionnaire was selected to measure health-related quality of life (HRQOL) which was recommended in older adults and people with mild dementia (Aguirre, Kang, Hoare, Edwards, & Orrell, 2016; León-Salas et al., 2015). According to the self-report index scores, it can be converted to a single summary utility score by using the time trade-off (TTO) technique. The range of this EQ-5D-3L utility score (EQ5D-Utility) was -0.67 to 1.00 by using the Taiwanese value set (Lee et al., 2013), as the score closer to 1 indicated the better health, a negative score indicated worse than dead, and a 0.5 score could be acceptable.

  32. Quality of Life-EQ5D-Utility

    Time frame: Immediately after intervention.

    EQ-5D-3L Taiwanese version questionnaire was selected to measure health-related quality of life (HRQOL) which was recommended in older adults and people with mild dementia (Aguirre, Kang, Hoare, Edwards, & Orrell, 2016; León-Salas et al., 2015). According to the self-report index scores, it can be converted to a single summary utility score by using the time trade-off (TTO) technique. The range of this EQ-5D-3L utility score (EQ5D-Utility) was -0.67 to 1.00 by using the Taiwanese value set (Lee et al., 2013), as the score closer to 1 indicated the better health, a negative score indicated worse than dead, and a 0.5 score could be acceptable.

  33. Quality of Life-EQ5D-Utility

    Time frame: At 4 weeks after intervention.

    EQ-5D-3L Taiwanese version questionnaire was selected to measure health-related quality of life (HRQOL) which was recommended in older adults and people with mild dementia (Aguirre, Kang, Hoare, Edwards, & Orrell, 2016; León-Salas et al., 2015). According to the self-report index scores, it can be converted to a single summary utility score by using the time trade-off (TTO) technique. The range of this EQ-5D-3L utility score (EQ5D-Utility) was -0.67 to 1.00 by using the Taiwanese value set (Lee et al., 2013), as the score closer to 1 indicated the better health, a negative score indicated worse than dead, and a 0.5 score could be acceptable.

  34. Quality of Life-EQ5D-Utility

    Time frame: At 12 weeks after intervention.

    EQ-5D-3L Taiwanese version questionnaire was selected to measure health-related quality of life (HRQOL) which was recommended in older adults and people with mild dementia (Aguirre, Kang, Hoare, Edwards, & Orrell, 2016; León-Salas et al., 2015). According to the self-report index scores, it can be converted to a single summary utility score by using the time trade-off (TTO) technique. The range of this EQ-5D-3L utility score (EQ5D-Utility) was -0.67 to 1.00 by using the Taiwanese value set (Lee et al., 2013), as the score closer to 1 indicated the better health, a negative score indicated worse than dead, and a 0.5 score could be acceptable.

  35. Quality of Life-EQ5D-Utility

    Time frame: At 24 weeks after intervention.

    EQ-5D-3L Taiwanese version questionnaire was selected to measure health-related quality of life (HRQOL) which was recommended in older adults and people with mild dementia (Aguirre, Kang, Hoare, Edwards, & Orrell, 2016; León-Salas et al., 2015). According to the self-report index scores, it can be converted to a single summary utility score by using the time trade-off (TTO) technique. The range of this EQ-5D-3L utility score (EQ5D-Utility) was -0.67 to 1.00 by using the Taiwanese value set (Lee et al., 2013), as the score closer to 1 indicated the better health, a negative score indicated worse than dead, and a 0.5 score could be acceptable.

  36. Quality of Life-EQ5D-visual analogue scale

    Time frame: At baseline.

    A 20-cm visual analogue scale in which respondents are asked to rate their current health status ranging from 0 (Worst imaginable health state) to 100 (Chang et al., 2007; EuroQol Research Foundation, 2018).

  37. Quality of Life-EQ5D-visual analogue scale

    Time frame: Immediately after intervention.

    A 20-cm visual analogue scale in which respondents are asked to rate their current health status ranging from 0 (Worst imaginable health state) to 100 (Chang et al., 2007; EuroQol Research Foundation, 2018).

  38. Quality of Life-EQ5D-visual analogue scale

    Time frame: At 4 weeks after intervention.

    A 20-cm visual analogue scale in which respondents are asked to rate their current health status ranging from 0 (Worst imaginable health state) to 100 (Chang et al., 2007; EuroQol Research Foundation, 2018).

  39. Quality of Life-EQ5D-visual analogue scale

    Time frame: At 12 weeks after intervention.

    A 20-cm visual analogue scale in which respondents are asked to rate their current health status ranging from 0 (Worst imaginable health state) to 100 (Chang et al., 2007; EuroQol Research Foundation, 2018).

  40. Quality of Life-EQ5D-visual analogue scale

    Time frame: At 24 weeks after intervention.

    A 20-cm visual analogue scale in which respondents are asked to rate their current health status ranging from 0 (Worst imaginable health state) to 100 (Chang et al., 2007; EuroQol Research Foundation, 2018).

Sponsors and collaborators

Lead sponsor

Taipei Medical University

Other

Collaborators

  • Ministry of Science and Technology, Taiwan

Registry information

Official study title

Evaluation of Computerized Virtual Reality on FunctionalAbility and Quality of Life in Elderly

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
Jul 30, 2021
Registry last updated
Jul 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.